Sr. Account Director, Cell & Gene Therapy
Catalent Pharma Solutions
Summary
Catalent is seeking a Senior Account Director, Cell & Gene Therapy to drive new business acquisitions across our Cell & Gene Therapy manufacturing network. This field-based, hunter-focused role is responsible for identifying, pursuing, and securing new business opportunities with biopharmaceutical companies.
Job description
Position Summary
Catalent is seeking a Senior Account Director, Cell & Gene Therapy to drive new business acquisitions across our Cell & Gene Therapy manufacturing network. This field-based, hunter-focused role is responsible for identifying, pursuing, and securing new business opportunities with biopharmaceutical companies.
The Account Director will serve as a trusted partner, evaluating customer development and manufacturing needs, positioning Catalent's Cell & Gene Therapy solutions, and leading opportunities from initial engagement through contract execution. Success in this role requires a proactive business development mindset, strong relationship-building skills, and the ability to navigate complex outsourcing decisions within the biotech and pharmaceutical industry.
The Role
- Develop and secure new business opportunities with pharmaceutical and biotechnology companies through proactive prospecting and relationship building.
- Lead early-stage opportunity qualification by assessing customer needs, strategic fit, and outsourcing requirements in partnership with internal technical and commercial teams.
- Present Catalent's Cell & Gene Therapy capabilities and value proposition to prospective clients through meetings, presentations, and site visits.
- Drive opportunities through the sales process, including solution development, scope definition, pricing strategy, and proposal delivery.
- Build long-term customer relationships that maximize revenue growth, support successful project execution, and generate future business opportunities.
- Other duties as assigned.
Candidate Requirements
- Master's degree or equivalent work experience in Cell and Gene Therapy or related life sciences fields.
- Minimum 5 years of life sciences commercial experience with a strong consultative focus on selling CDMO/CRO services, custom projects, or biomanufacturing services.
- Proven track record of developing and closing business opportunities within the biopharmaceutical sector.
- Experience building relationships with stakeholders ranging from technical teams to executive leadership.
- Strong business acumen, strategic selling skills, and the ability to manage multiple priorities in a fast-paced environment.
Preferred Skills & Background
- Experience supporting Cell & Gene Therapy development and manufacturing programs.
- Established knowledge of and relationships within the West Coast biopharmaceutical market.
Requirements
- Master's degree or equivalent work experience in Cell and Gene Therapy or related life sciences fields.
- Minimum 5 years of life sciences commercial experience with a strong consultative focus on selling CDMO/CRO services, custom projects, or biomanufacturing services.
- Proven track record of developing and closing business opportunities within the biopharmaceutical sector.
- Experience building relationships with stakeholders ranging from technical teams to executive leadership.
- Strong business acumen, strategic selling skills, and the ability to manage multiple priorities in a fast-paced environment.
- Experience supporting Cell & Gene Therapy development and manufacturing programs.
- Established knowledge of and relationships within the West Coast biopharmaceutical market.
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Tuition Reimbursement
- Professional Development
- Paid Time Off
- Holiday Schedule
- Sales Incentive Plan
Company overview
Catalent Pharma Solutions, now known as Catalent, Inc., is a leading global contract development and manufacturing organization (CDMO) headquartered in Tampa, Florida. Founded in 2007 as a spin-off from Cardinal Health's pharmaceutical technologies segment, the company has grown into a major player in the pharmaceutical services industry. Catalent provides comprehensive drug development and manufacturing solutions including drug delivery technologies, formulation development, analytical testing, clinical and commercial manufacturing, clinical packaging, and supply chain services. The company operates over 50 facilities across four continents and has supported more than half of all FDA-approved products over the past decade. With approximately 16,900 employees, Catalent produces over 70 billion doses annually for more than 8,000 products, serving major pharmaceutical companies like Pfizer, Moderna, Novo Nordisk, and Bristol-Myers Squibb. In 2024, the company was acquired by Novo Holdings A/S for $16.5 billion, further strengthening its position in the global pharmaceutical manufacturing landscape.